Todd B. Sherer, PhD

Michael J Fox Foundation 
"Todd Sherer"
Mean distance: 17.21 (cluster 32)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Schiess N, Cataldi R, Okun MS, et al. (2022) Six Action Steps to Address Global Disparities in Parkinson Disease: A World Health Organization Priority. Jama Neurology
Espay AJ, Kalia LV, Gan-Or Z, et al. (2020) Disease modification and biomarker development in Parkinson disease: Revision or reconstruction? Neurology
Dorsey E, Sherer T, Okun M, et al. (2020) The Rise of Parkinson's Disease American Scientist. 108: 176
Espay AJ, Vizcarra JA, Marsili L, et al. (2019) Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. Neurology. 92: 329-337
Prakash N, Caspell-Garcia C, Coffey C, et al. (2019) Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI). Parkinsonism & Related Disorders
Dorsey ER, Sherer T, Okun MS, et al. (2018) The Emerging Evidence of the Parkinson Pandemic. Journal of Parkinson's Disease. 8: S3-S8
Marek K, Chowdhury S, Siderowf A, et al. (2018) The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort. Annals of Clinical and Translational Neurology. 5: 1460-1477
Chen-Plotkin AS, Albin R, Alcalay R, et al. (2018) Finding useful biomarkers for Parkinson's disease. Science Translational Medicine. 10
Simuni T, Siderowf A, Lasch S, et al. (2018) Longitudinal change of clinical and biological measures in early Parkinson's disease: Parkinson's progression markers initiative cohort. Movement Disorders : Official Journal of the Movement Disorder Society
Sherer TB, Frasier MA, Langston JW, et al. (2016) Parkinson's disease is ready for precision medicine. Personalized Medicine. 13: 405-407
See more...